SARS-CoV-2 vaccine (Virginia Tech University)

N/A

Report date: 2025/01/26 16:18:26

Base Information

Drug NameSARS-CoV-2 vaccine (Virginia Tech University)

Drug Alias NameSARS-CoV-2 vaccine (Virginia Tech University)

ClassificationVaccines > Development/production technology > Inactivated vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionCoronavirus spike glycoprotein modulators

TargetsCoronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVirginia Polytechnic Institute and State University

China Registration ClassN/A

Develop Information

Active CompaniesVirginia Polytechnic Institute and State University

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A